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Introduction
• Approx.	25%	of	deaths	in	Westernized	
countries	are	attributed	to	cancer.1
• The	typical	Western-diet	is	associated	with	
higher	risks	of	colorectal	cancer	(CRC)	
compared	to	a	balanced	diet.
• Tart	cherries	are	rich	in	anthocyanins	(a	
group	of	antioxidants)	and	have	many	
benefits	including	prevention	of	cancer	and	
inflammatory	diseases.
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Results	
Conclusions
• Consumption	of	TWD	markedly	enhanced	
colitis,	inflammation,	mucosal	injury	and	
tumor	burden	in	comparison	to	AIN93G.
• Consumption	of	AIN93G	with	tart	cherries	
reduced	tumor	incidence,	but	did	not	affect	
other	parameters	measured.
• Careful	consideration	must	be	given	to	the	
role	of	basal	diet	in	dietary	
chemoprevention	studies	in	rodents.
Study	conducted	with	funding	from	Utah	Agriculture	Experiment	Station	(UTA-01178)	and	USDA	NIFA	Grant	
#2013-03494.	Technical	Assistance	from	Veronica	Martel	and	Tess	Armbrust.
1.	Boyle,	P.	and	J.S.	Langman.	ABC	of	colorectal	cancer.	Epidemiology.	BMJ,	2000.	321(7264):805-8
Figure	2	– Cancer	outcome
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Data	shown	are	incidence	(percentage	of	
mice	with	colon	tumors)	and	the	mean	+	
SEM	tumor	burden	(total	volume	of	tumor	
tissue	per	mouse)	(n	=	21	to	24	mice	per	
group).		Bars	with	different	letters	are	
statistically	different.
Methods
• Mice	were	fed	a	standard	diet	(AIN93G)	
or	the	total	Western	diet	(TWD)	with	or	
without	tart	cherry	supplementation	
(anthocyanin	content	at	188	ppm).	
• Mice	were	injected	with	the	carcinogen	
azoxymethane	(AOM)	and	provided	1%	
dextran	sodium	sulfate	(DSS)	for	10	days.	
• Mice	from	each	dietary	group	were	
randomly	selected	to	be	necropsied	at	1,	
7,	9	and	15	weeks.	
• Endpoints	included	food	and	water	
consumption,	body	weight	and	
composition,	feces,	and	tissues	including	
the	colon,	liver,	and	cecum.
Figure	1	– Colonic	Inflammation	and	Mucosal	Injury
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Model	for	current	investigations	by	our	laboratory	
on	the	interactions	between	basal	diet,	functional	
foods	&	their	bioactive	chemicals	and	the	gut	
microbiome	and	how	these	factors	influence	gut	
inflammation	and	development	of	inflammation-
associated	colorectal	cancer	in	mice.
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Each	colon	was	blindly	scored	based	extent	of	inflammation,	regeneration	of	the	epithelium,	
crypt	damage	and	percent	of	the	colon	involved.	Within	each	disease	stage,	bars	with	
different	letters	are	statistically	different.
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Design	of	pre-clinical	study	to	test	efficacy	of	tart	
cherry	supplementation	in	mouse	model	of	
inflammation-associated	CRC.
